Back to search
CDKL5 Deficiency Disorder (CDD)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which CDKL5 Deficiency Disorder (CDD) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which CDKL5 Deficiency Disorder (CDD) trials you may qualify forStandard anti-seizure medications have limited efficacy in seizure control in cyclin-dependent kinase-like 5 deficiency disorder (CDD). The study will investig…
Pathogenic variants in the Cyclin-dependent kinase like 5 (CDKL5) gene cause CDKL5 deficiency disorder (CDD, MIM 300672, 105830), a severe developmental and epi…
This is a Phase 3 Study to examine the efficacy and safety of ZX008 in children and adults with cyclin-dependent kinase like-5 (CDKL5) deficiency disorder (CDD)…
Owing to the recent classification of CDKL5 Deficiency Disorder (CDD) as a unique disorder, there is a limited understanding of overall disease natural history…
This study will assess the efficacy, safety, and tolerability of ganaxolone (GNX) compared with placebo (PBO) as adjunctive therapy to the participant's standar…